SPHK2 and chronic obstructive pulmonary disease: These data indicated that S1P signaling plays a critical role in CS-induced COPD development, suggesting that targeting SphK2, which is responsible for S1P section post-CS exposure, is an effective therapeutic strategy against COPD.